1,865
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity

, , , , , & show all
Pages 99-105 | Received 24 Jul 2016, Accepted 31 Aug 2016, Published online: 25 Oct 2016

References

  • Gadad AK. Mahajanshetti CS, Nimbalkar S, Raichurkar A. Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3, 4-thiadiazole-2-sulfonamide derivatives. Eur J Med Chem 2000;9:853–7.
  • Mojzych M, Bielawska A, Bielawski K, et al. Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity. Bioorg Med Chem 2014;22:2643–7.
  • Zani F, Vicini P. Antimicrobial activity of some 1,2-benzisothiazoles having a benzenesulfonamide moiety. Arch Pharm 1998;331:219–23.
  • Brzozowski Z, S1awinski J, Saczewski F, et al. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides. Eur J Med Chem 2010;45:2396–404.
  • Renzi G, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties. Bioorg Med Chem Lett 2000;10:673–6.
  • Maren TH. Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev 1967;47:595–781.
  • Maren TH. Relatons between structure and biological activity of sulfonamides. Ann Rev Pharmacol Toxicol 1976;16:309–27.
  • Drew J. Drug discovery: a historical perspective. Science 2000;287:1960–194.
  • Li JJ, Anderson D, Burton EG, et al. 1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. J Med Chem 1995;38:4570–8.
  • Mojzych M, Dolashki A, Voelter W. Synthesis of pyrazolo[4,3-e][1,2,4]triazine sulfonamides, novel Sildenafil analogs with tyrosinase inhibitory activity. Bioorg Med Chem 2014;22:6616–24.
  • Khan KM, Maharvi GM, Perveen S, et al. Synthesis of methyl ether analogues of sildenafil (Viagra®) possessing tyrosinase inhibitory potential. Chem Biodivers 2005;2:470–6.
  • Saeed A, Mahmood S-u, Rafiq M, et al. Iminothiazoline-sulfonamide hybrids as jack bean urease inhibitors; Synthesis, kinetic mechanism and computational molecular modeling. Chem Biol Drug Des 2016;87:434–43.
  • Gawande SS, Warangkar SC, Bandgar BP, Khobragade CN. Synthesis of new heterocyclic hybrids based on pyrazole and thiazolidinone scaffolds as potent inhibitors of tyrosinase. Bioorg Med Chem 2013;21:2772–7.
  • Chen Z, Cai D, Mou D, et al. Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted 5-benzylidene(thio) barbiturates as novel tyrosinase inhibitors. Bioorg Med Chem 2014;22:3279–84.
  • Chan C–F, Lai S–T, Guo Y–C, Chen M–J. Inhibitory effects of novel synthetic methimazole derivatives on mushroom tyrosinase and melanogenesisOriginal. Bioorg Med Chem 2014;22:2809–15.
  • Yoshimori A, Oyama T, Takahashi S, et al. Structure–activity relationships of the thujaplicins for inhibition of human tyrosinase. Bioorg Med Chem 2014;22:6193–200.
  • Komori Y, Imai M, Yamauchi T, et al. Effect of p-aminophenols on tyrosinase activity. Bioorg Med Chem 2014;22:3994–4000.
  • Xiao Z-P, Peng Z-Y, Dong J-J, et al. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors. Eur J Med Chem 2013;68:212–21.
  • Khan KM, Naz F, Taha M, et al. Synthesis and in vitro urease inhibitory activity of N,N′-disubstituted thioureas. Eur J Med Chem 2014;74:314–23.
  • Chen W, Li Y, Cui Y, et al. Synthesis, molecular docking and biological evaluation of Schiff base transition metal complexes as potential urease inhibitors. Eur J Med Chem 2010;45:4473.
  • Khan KM, Rahim F, Khan A, et al. Synthesis and structure–activity relationship of thiobarbituric acid derivatives as potent inhibitors of urease. Bioorg Med Chem 2014;22:4119–23.
  • Rykowski A, Makosza M. Reaction of 1,2,4-triazines with nitronate anions, direct nucleophilic acylation of 1,2,4-triazines. Tetrahedron Lett 1984;25:4795–6.
  • Rykowski A, Lipinska T. A concise route to a key intermediate in the total synthesis of sempervirine. Commun 1996;26:4409–14.
  • Mojzych M, Kubacka M, Mogilski S, et al. Relaxant effects of selected sildenafil analogues in the rat aorta. J Enzyme Inhib Med Chem 2015;31:381–8.
  • Seo WD, Ryu YB, Curtis-Long MJ, et al. Evaluation of anti-pigmentary effect of synthetic sulfonylamino chalcone. Eur J Med Chem 2010;45:2010–17.
  • Ashraf Z, Rafiq M, Seo S-Y, et al. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors. J Enzyme Inhib Med Chem 2015;30:874–3.
  • Weatherburn MW. Phenol-hypochlorite reaction for determination of ammonia. Anal Chem 1967; 39:971–4.
  • Chiari ME, Vera DMA, Palacios SM, Carpinella MC. Tyrosinase inhibitory activity of a 6-isoprenoid-substituted flavanone isolated from Dalea elegans. Bioorg Med Chem 2011;19:3474–82.
  • Ghani U, Ullah N. New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site. Bioorg Med Chem 2010;18:4042–8.
  • Amtul Z, Kausar N, Follmer C, et al. Cysteine based novel noncompetitive inhibitors of urease(s)-distinctive inhibition susceptibility of microbial and plant ureases. Bioorg Med Chem 2006; 16:6737–44.
  • Rykowski A, Mojzych M, Karczmarzyk Z. A new synthesis of pyrazolo[4,3-e][1,2,4]triazines via acid promoted ring closure of the phenylhydrazones of 5-acyl-1,2,4-triazines. Heterocycles 2000;53:2175–85.
  • Mojzych M, Rykowski A. Transformations of phenylhydrazones of 5-acyl-1,2,4-triazines to pyrazolo[4,3-e][1,2,4]triazines or 4-cyanopyrazole. J Heterocycl Chem 2007;44:1003–7.
  • Alphonse F-A, Suzenet F, Keromnes A, et al. Palladium-catalyzed 3-thiomethyltriazine-boronic acid cross coupling: easy access to 3-substituted-1,2,4-triazines. Synlett 2002;3:447–50.